Current HIV prevention efforts have and continue to fail Black same-gender-loving (SGL)* men. But with meaningful reflection and changes to service delivery, this can change.
Thirty years ago, a group of scientists gathered around a kitchen table on Davie Street, in the heart of Vancouver’s West End, to discuss ways to provide better care for and prolong the lives of people living with HIV who, at the time, were dying by the hundreds and extremely stigmatized. In Canada, there was not yet a network for physicians to come together and conduct HIV clinical trials. And so, the CIHR Canadian HIV Trials Network (CTN) was born, providing a platform for Canadian researchers to generate good scientific evidence.
Does your organization support the meaningful engagement of individuals with lived experience of substance use? The assumption and our immediate response to this question should be a resounding yes! However, we know that this is often not the case.
Les Britanno-Colombiens peuvent désormais recevoir un diagnostic d’hépatite C à partir d’une seule analyse de sang, ce qui représente une économie de temps et d’argent pour les patients et le système de soins de santé. En effet, une nouvelle procédure de dépistage a été adoptée par le laboratoire de santé publique du Centre de contrôle des maladies de la Colombie-Britannique (BCCDC), connue sous le nom de test systématique de dépistage de l’ARN du virus de l’hépatite C (VHC).
To end the HIV epidemic in Canada, it is important for people who are HIV-positive to know their status and to be linked to care. To do that, we have to reach people who are not testing now and make the process easier for them.
Many creative solutions have been implemented to keep people who use drugs safe, and these solutions need to be scaled up and continued beyond the pandemic, to reach people who don’t live in areas with adequate harm reduction services.
